Join John Wilding, Kamlesh Khunti and Julie Lovshin for a live webinar on the continuing evolution of glucagon-like peptide-1 receptor agonist. The expert faculty will discuss the current and future treatment landscapes for type 2 diabetes (T2D), with a focus on once-weekly and next generation glucagon-like peptide-1 receptor agonists (GLP-1RAs).
You will have the opportunity to pose questions to our panel of experts throughout the session, and interact by answering live questions to promote peer-to-peer engagement and debate.
The continuing evolution of GLP-1RAs webinar has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 1 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.
Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
For more information about the webinar click here.
This activity is made possible thanks to an independent educational grant from Novo Nordisk A/S.